New service to ease short term strain on the NHS – you can volunteer now
Licence update for BOTOX® increases involvement of MDT
News of BOTOX® licence update
Virtual education and specialist understanding amidst the COVID-19 pandemic
Amended course dates and webinars from the MS Academy
Fremanezumab – first anti-CGRP preventive therapy approved by NICE
Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)
Data from Phase III Trial “SPI2” for Treatment of Progressive MS
News from MedDay Pharma
£1.68m to fund research in intracranial hypertension for Birmingham researcher
Professor Alexandra Sinclair, University of Birmingham awarded £1.68m to fund research into intracranial hypertension
Essex collaboration focuses on people living with neurological conditions
Research news from The University of Essex
Topline results of Phase 1-2 CDNF trial
Industry news from Herantis Pharma
Brain Tumour Support: Sparkle up your day
Charity news from Brain Tumour Support